Kadera, B. E., Toste, P. A., Wu, N., Li, L., Nguyen, A. H., Dawson, D. W., & Donahue, T. R. (2014). Low expression of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and is Targeted by Epidermal Growth Factor Receptor Inhibition. Clin Cancer Res.
Citación estilo ChicagoKadera, Brian E., Paul A. Toste, Nanping Wu, Luyi Li, Andrew H. Nguyen, David W. Dawson, y Timothy R. Donahue. "Low Expression of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and Is Targeted By Epidermal Growth Factor Receptor Inhibition." Clin Cancer Res 2014.
Cita MLAKadera, Brian E., et al. "Low Expression of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and Is Targeted By Epidermal Growth Factor Receptor Inhibition." Clin Cancer Res 2014.